Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.
Friend R, Bhutani M, Voorhees PM, Usmani SZ. Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma. Drug Des Devel Ther. 2017; 11:893-900.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Humans
Multiple Myeloma
Signaling Lymphocytic Activation Molecule Family
authors with profiles
Saad Usmani MD